You can buy or sell UroGen Pharma and other stocks, options, ETFs, and crypto commission-free!
UroGen Pharma Ltd. Ordinary Shares, also called UroGen Pharma, is a clinical stage pharmaceutical company, which engages in the provision of non-surgical and localized solutions for urological pathologies to address a clinical unmet need in field of uro-oncology. Read More Its pipeline includes upper tract urothelial carcinoma, low grade non muscle invasive bladder cancer, carcinoma in situ of the bladder, and overactive bladder. The company was founded by Asher Holzer in 2004 and is headquartered in Ra'anana, Israel.
New York, New York
52 Week High
52 Week Low
Expected Nov 11, Pre-Market